Mortality of Metalloporphyrin-Treated Neonatal Rats after Light Exposure
Authors:
- 1 January 1990
- journal article
- research article
- Published by S. Karger AG in Developmental Pharmacology and Therapeutics
- Vol. 14 (3) , 187-192
Abstract
Tin protoporphyrin (SnPP) has been used to suppress hyperbilirubinemia in human neonates through inhibition of heme oxygenase. Some of the subjects exhibited mild erythema upon receiving phototherapy. SnPP and three proposed alternatives, tin mesoporphyrin(SnMP), zinc protoporphyrin (ZnPP) and zinc mesoporphyrin (ZnMP) are potential photosensitizers. We therefore studied the phototoxic effects of these compounds in the neonatal rat model. Fed Wistar rats (24-36 h old) were injected intraperitoneally with up to 40 μmol SnPP/kg body weight, 30 μmol SnMP/kg body weight, 60 μmol ZnPP/kg body weight, or 45 μmol ZnMP/kg body weight. The animals were placed over cool white light(20 μW/cm^2/nm) for 12 h. Light exposure resulted in SnPP dose-dependent mortality, and the LD(50) was determined to be 11.7 μmol/kg body weight. No deaths were observed in pups treated with up to 20 μmol SnMP/kg; treatment with 30 μmol SnMP/kg resulted in a 40 %mortality rate. No fatalities were observed among the ligth-exposed ZnPP- or ZnMP-treated pups. No deaths were observed among control pups treated with the highest metalloporphyrin doses and kept in the dark; similarly, no mortality was observed in untreated lightexposed control animals. We conclude that (1) SnPP and SnMP are potentially fatal phototoxic substances in the neonatal rat; (2) ZnPP and ZnMP may be safer drugs for neonatal rats receiving light exposure, and (3) further studies are needed to fully assess the photobiological hazards of metalloporphyrin administration to humans.Keywords
This publication has 12 references indexed in Scilit:
- Photophysical Properties of Sn-Porphyrins: Potential Clinical ImplicationsPediatrics, 1988
- Lack of Inhibition of Intestinal Heme Oxygenase by Antibiotics and Tin-ProtoporphyrinPediatric Research, 1988
- Reduction of the C2 and C4 vinyl groups of Sn-protoporphyrin to form Sn-mesoporphyrin markedly enhances the ability of the metalloporphyrin to inhibit in vivo heme catabolismArchives of Biochemistry and Biophysics, 1987
- Disposition of tin-protoporphyrin and suppression of hyperbilirubinemia in humansClinical Pharmacology & Therapeutics, 1986
- TIN‐PROTOPORPHYRIN: A POTENT PHOTOSENSITIZER OF BILIRUBIN DESTRUCTIONPhotochemistry and Photobiology, 1985
- Prevention of Neonatal Hyperbilirubinemia in Rhesus Monkeys by Tin-protoporphyrinPediatric Research, 1984
- Tissue distribution and disposition of tin-protoporphyrin, a potent competitive inhibitor of heme oxygenase.The Journal of Pharmacology and Experimental Therapeutics, 1984
- Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation.Journal of Biological Chemistry, 1982
- Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.Proceedings of the National Academy of Sciences, 1981
- Zinc · protoporphyrin is a selective inhibitor of heme oxygenase activity in the neonatal ratBiochimica et Biophysica Acta (BBA) - General Subjects, 1981